Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis
Benedikt Hofer(Austrian Academy of Sciences), Thomas Gremmel(Landesklinikum Korneuburg), Benedikt Simbrunner(Austrian Academy of Sciences), Lukas Hartl(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Beate Eichelberger(Medical University of Vienna), Silvia Lee(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Lorenz Balcar(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Simon Panzer, Ksenia Brusilovskaya(Austrian Academy of Sciences)
Cited by 17
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119